Table 1.
Meta-analysis of the included studies
| Group/subgroup | Included studies | Total sample size (n) | Pooled proportion (%) | 95% CI | Heterogeneity | ||
|---|---|---|---|---|---|---|---|
| I2% (inconsistency) | Cochran Q | P value | |||||
| MRSA | 64 | 7171 | 63 | [55–70] | 98.66 | 4686.37 | < 0.01 |
| Based on the detection method of MRSA | |||||||
| PCR | 31 | 2934 | 66 | [58–75] | 98.02 | 1513.88 | < 0.01 |
| CDD | 34 | 4307 | 66 | [56–76] | 98.85 | 2872.75 | < 0.01 |
| ODD | 22 | 2417 | 60 | [48–73] | 98.48 | 1381.00 | < 0.01 |
| Based on region | |||||||
| Cairo | 14 | 1333 | 67 | [54–81] | 97.26 | 475.08 | < 0.01 |
| Mansoura | 15 | 2606 | 59 | [40–77] | 99.48 | 2697.25 | < 0.01 |
| Zagazig | 5 | 630 | 67 | [38–95] | 98.93 | 375.58 | < 0.01 |
| Alexandria | 6 | 569 | 61 | [47–75] | 92.45 | 66.24 | < 0.01 |
| Assiut | 3 | 223 | 73 | [49–97] | 94.48 | 36.21 | < 0.01 |
| Tanta | 4 | 498 | 40 | [18–61] | 96.79 | 93.38 | < 0.01 |
| Sample size | |||||||
| Below 50 | 11 | 318 | 71 | [59–83] | 86.47 | 73.91 | < 0.01 |
| 50–99 | 23 | 1781 | 69 | [59–78] | 97.62 | 925.15 | < 0.01 |
| Above 100 | 30 | 5072 | 55 | [45–66] | 98.73 | 2276.78 | < 0.01 |
Abbreviation: MRSA methicillin-resistant staphylococcus aureus, CDD cefoxitin disc diffusion, ODD Oxacillin disc diffusion